Immune system changes may predict antipsychotic resistance in schizophrenia Scientis…

Researchers from the National Healthcare Group (NHG)’s Institute of Mental Health (IMH) and Agency for Science, Technology and Research (A*STAR) have made strides in understanding the connection between the immune system and resistance to antipsychotic medications in schizophrenia, using changes in immune cell populations to predict potential treatment resistance and initiate the most appropriate treatment sooner.

New initiative aims to transform how Alzheimer’s disease is diagnosed, treated across healthcare settings

Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer’s research, implementation science,

January 31, 2024

Signal: UK clinical research provider Ergomed bought out in $888m deal – Pharmaceutical Technology

Private equity fund Permira has announced that it is acquiring Ergomed. Photo: T. Schneider / Shutterstock. UK private equity firm Permira has announced an agreement

September 4, 2023

Ironwood’s stock drops 40% as short bowel syndrome drug shows mixed efficacy in PhIII

Ironwood Pharmaceuticals’ GLP-2 analog hit the primary endpoint in a registrational short bowel syndrome study, but fell short of key secondary outcomes in a slightly

March 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.